Medicare to Cover Biogen’s Alzheimer’s Drug in Trials
Medicare has reached a preliminary decision to cover Biogen’s Alzheimer’s drug, Aduhelm, for patients who are in approved clinical trials.
Biogen Announced New Data from Its Alzheimer’s Drug Aduhelm Sent Shares Up
Biogen announced that new data of their Alzheimer’s drug, Aduhelm, shows it can lower levels of a second protein that causes Alzheimer’s. Biogen’s shares rose more than 3% in after…